COVID-19 疫情后子宫内膜癌手术患者当日出院率提高
回顾性队列研究纳入某大型学术机构2019年9月1日至2020年10月1日因子宫内膜癌行微创手术的166例患者,比较COVID-19限制实施前80例与实施后86例。疫情开始后当日出院率提高18%(40% vs 58%,p = .02),30天再入院率无差异(7.5% vs 5.8%,p = .66)。
要点
- 疫情开始后当日出院率由40%升至58%,提高18%(p = .02)。
- 多变量logistic回归中,COVID-19组当日出院的比值比为3.08(95%CI 1.40-6.74;p = .01)。
- 30天再入院率两组无显著差异(7.5% vs 5.8%,p = .66)。
核心结论
- 自COVID-19疫情开始以来,子宫内膜癌患者的当日出院率显著增加。
- 疫情使医院资源紧张,并促使患者和医生避免住院;这表明在适当动机下,当日出院率可以提高而不增加并发症或再住院。
研究设计与样本
- 回顾性队列研究,在某教学医院开展。
- 纳入2019年9月1日至2020年10月1日因子宫内膜癌指征行微创手术的166例患者:COVID-19限制实施前80例,实施后86例。
- 干预为2020年3月17日实施的COVID-19疫情相关探视限制与医院政策变更。
主要发现
- 疫情开始后当日出院率提高18%(40% vs 58%,p = .02)。
- 两组在手术时间(p = .07)、估计失血量(p = .21)、子宫重量(p = .12)、年龄(p = .06)、体质指数(p = .42)及手术开始时间(p = .15)方面均无差异。
- 多变量logistic回归模型中,COVID-19组当日出院的比值比是COVID-19前组的3.08倍(95%CI 1.40-6.74;p = .01)。
- 30天再入院率无差异(7.5% vs 5.8%,p = .66)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To determine the effect of the coronavirus disease 2019 (COVID-19) pandemic on the rate of same-day discharge (SDD) after minimally invasive surgery for endometrial cancer. DESIGN: Retrospective cohort. SETTING: Teaching hospital. PATIENTS: A total of 166 patients underwent a minimally invasive surgery procedure for the indication of endometrial cancer at a large academic institution from September 1, 2019, to October 1, 2020-80 patients before the implementation of the COVID-19 restrictions and 86 patients after. INTERVENTIONS: COVID-19 pandemic with visitor restrictions and hospital policy changes placed on March 17, 2020. MEASUREMENTS AND MAIN RESULTS: SDD rate was increased by 18% after the start of the COVID-19 pandemic (40% vs 58%, p = .02). There were no differences between the 2 groups with regard to operative time (p = .07), estimated blood loss (p = .21), uterine weight (p = .12), age (p = .06), body mass index (p = .42), or surgery start time (p = .15). In a multivariable logistic regression model, subjects in the COVID-19 group had 3.08 times (95% confidence interval, 1.40-6.74; p = .01) higher odds of SDD than those in the pre-COVID-19 group. There was no difference in 30-day readmission rates (7.5% vs 5.8%, p = .66). CONCLUSION: There was a significant increase in the SDD of patients with endometrial cancer since the start of the COVID-19 pandemic. The pandemic has strained hospital resources and motivated patients and physicians to avoid hospitalization. This shows that with proper motivation, an increase in SDD rates is possible without an increase in complications or rehospitalization.
引用
- Lees BF, Johnson S, Donahue E, et al. Improved Rates of Same-day Discharge in Patients Undergoing Surgery for Endometrial Cancer Following the COVID-19 Pandemic. J Minim Invasive Gynecol. 2022. PMID: 35940525. doi:10.1016/j.jmig.2022.07.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。